Last reviewed · How we verify
NCT07200648: BIG:LEAP
Basic Income Guaranteed: Los Angeles Economic Assistance Pilot
NA trial testing Unconditional cash transfer in Financial Wellbeing in 8,194 participants. Completed in 31 August 2024.
30 September 2023
Quick facts
| Lead sponsor | University of Pennsylvania |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 8,194 |
| Start date | 1 December 2021 |
| Primary completion | 30 September 2023 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Unconditional cash transfer
Conditions studied
- Financial Wellbeing — all drugs for Financial Wellbeing →
- Psychological Distress — all drugs for Psychological Distress →
- Physical Functioning — all drugs for Physical Functioning →
- Housing — all drugs for Housing →
Sponsor
University of Pennsylvania
Who can join
18 and older, any sex, with Financial Wellbeing or Psychological Distress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized controlled trial is to learn if receipt of a guaranteed income works to reduce financial hardship and improve quality of life. The main questions it aims to answer are: 1. How does GI affect participants' quality of life? 2. What is the relationship between GI and participants' subjective sense of self? 3. How does GI affect participants' income, and through what mechanisms? 4. How does the implementation of GI inform the existing safety net? Participants will: Receive an recurring unconditional cash transfer of $1,000 per month every month for 12 months OR receive no unconditional cash transfer Complete surveys at six month intervals during the course of the study Be invited to participate in in-depth interviews
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07200648
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Unconditional cash transfer
Trials testing the same drug.
- NCT06611982 — Guaranteed Income and Financial Treatment · NA · active not recruiting
Other University of Pennsylvania trials
Trials by the same sponsor.
- NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
- NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
- NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
- NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
- NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07200648 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
- Last refreshed: 1 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07200648.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing